carocell bio

menu.png

carocell

Initial proof of concept can open the market to treat other serious inflammatory diseases and so target the $106B inflammatory market with a more safe and effective peptide inhibitor.

The market for inflammation & anti-inflammatory products & treatment

Expected to reach $106 billion by 2020

Anti-Inflammatory Therapeutics Market Analysis:

The global market for anti-inflammatory treatments is expected to reach $106.1 billion by 2020.

Inflammation is triggered by the defense system of the body as a normal response to external influences and is the natural mechanism which attempts to eliminate any injury, clear dead cells and heal injured tissues. Sometimes, the bodies defense system triggers inflammation against its own cells, resulting in diseases such as arthritis, asthma and chronic obstructive pulmonary disease (COPD).

At this point in time, there is a real requirement for better and safer novel anti-inflammatory treatments that have no side effects. Existing treatments such as steroids, ibuprofen, paracetamol etc., all have serious drawbacks and limitations from this perspective.

Below are some of the typical diseases that our new treatments will be suitable to treat:

Inflammatory Bowel Disease (IBD)

  • Affects 200,000 people in UK - 45-50 new cases per hospital per year

  • 2.2 million people in the EU

  • 1.6million people in the US

  • 5 million people world-wide

  • $9.6 billion market

  • Current treatments tend to be ineffective or highly toxic

  • Initial target = mild-moderate disease (85%) and replace current treatments.

Atopic Dermatitis (AD, Eczema)

  • Very common, 10-20% of infants and young children experience symptoms
  • $6 billion market
  • Unmet need for a safe effective treatment

Burns

  • $1 billion and growing market
  • Unmet need for topical effective treatment

Carocell Bio has a clear plan to develop new, effective and safe treatments for serious inflammatory diseases :

  • Inflammatory Bowel Disease - JEL3108
  • Atopic dermatitis - JEL0305
  • Psoriasis - JEL1103
  • Burns and Acute Injuries - JEL2603
  • Other serious diseases
    • Asthma, COPD, sun burn, multiple sclerosis, cancer

 

READ ABOUT OUR RESEARCH 

FIND OUT HOW YOU CAN INVEST IN OUR TECHNOLOGY

donate to assist our research

If you would like to make a donation to Carocell Bio to help us advance our research into inflammation treatments, please use the donate button below.

 donate-words-icon.png

talk to carocell bio about investing in our work

If you would like to speak to us in detail about investing, tax benefits, donating or assisting us in any way at all, please contact us via the details below and we will get back to you as soon as possible.

talk-to-carocell-icon.png

bridge biotec facebookbridge biotec twitterbridge biotec linkedinbridge-youtube-60x60.png

Contact

Email: contact@carocellbio.com
UK: +44 (0) 20 3097 1979
US: +1 212 863 9902

USA Office

Carocell Bio, Inc.
3411 Silverside Road,
Tatnall Building,
Suite 104,
Wilmington,
New Castle,
Delaware,
DE 19810
U.S.A.

UK Office

©2018 Carocell Bio Ltd.

The BioHub at Alderley Park
Mereside, Alderley Park
Macclesfield
SK10 4TG